U.S. Physical Therapy (NYSE:USPH) Issues Quarterly Earnings Results, Misses Estimates By $0.07 EPS

U.S. Physical Therapy (NYSE:USPH) announced its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm had revenue of $155.70 million for the quarter, compared to the consensus estimate of $153.30 million. During the same period in the prior year, the firm posted $0.59 earnings per share. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year.

U.S. Physical Therapy Stock Performance

USPH traded up $0.47 on Friday, reaching $105.50. The company had a trading volume of 14,612 shares, compared to its average volume of 68,624. The stock has a market cap of $1.59 billion, a P/E ratio of 77.84, a P/E/G ratio of 4.99 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. U.S. Physical Therapy has a fifty-two week low of $78.08 and a fifty-two week high of $124.11. The company’s fifty day moving average is $105.32 and its 200 day moving average is $96.43.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date is Wednesday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is presently 130.37%.

Analyst Ratings Changes

A number of research analysts recently issued reports on USPH shares. Barrington Research restated an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a report on Thursday. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Finally, JPMorgan Chase & Co. raised their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $125.67.

Insider Activity

In related news, CFO Carey P. Hendrickson sold 1,800 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares in the company, valued at approximately $2,272,834.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, COO Graham D. Reeve sold 2,629 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.39, for a total value of $274,441.31. Following the transaction, the chief operating officer now directly owns 6,902 shares in the company, valued at $720,499.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the sale, the chief financial officer now owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,829 shares of company stock valued at $1,141,535. 1.70% of the stock is owned by insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.